Segment Information (Tables)

9 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Financial Information for Business Segments

The following is the summary of the financial information for the Company’s operating and reportable segments for the three and nine months ended June 30, 2018 and 2017 and balances as of June 30, 2018 and September 30, 2017(in thousands):

	Brooks
	Semiconductor		Brooks
	Solutions Group		Life Sciences		Total
Three Months Ended June 30, 2018:
Revenue
Products	$	150,675	$	23,438	$	174,113
Services		23,102		26,265		49,367
Segment revenue	$	173,777	$	49,703	$	223,480
Gross profit	$	70,634	$	18,587	$	89,221
Segment operating income		33,674		2,034		35,708
Depreciation expense		1,072		1,991		3,063
Three Months Ended June 30, 2017:
Revenue
Products	$	124,681	$	17,276	$	141,957
Services		20,280		19,480		39,760
Segment revenue	$	144,961	$	36,756	$	181,717
Gross profit	$	58,083	$	13,489	$	71,572
Segment operating income		26,188		1,134		27,322
Depreciation expense		1,192		1,134		2,326
Nine Months Ended June 30, 2018:
Revenue
Products	$	407,903	$	68,885	$	476,788
Services		66,481		76,799		143,280
Segment revenue	$	474,384	$	145,684	$	620,068
Gross profit	$	195,386	$	53,279	$	248,665
Segment operating income		90,872		4,577		95,449
Depreciation expense		3,354		5,579		8,933
Nine Months Ended June 30, 2017:
Revenue
Products	$	349,710	$	46,974	$	396,684
Services		56,532		57,789		114,321
Segment revenue	$	406,242	$	104,763	$	511,005
Gross profit	$	154,877	$	38,162	$	193,039
Segment operating income		63,562		2,535		66,097
Depreciation expense		3,786		3,269		7,055
Assets:
June 30, 2018	$	361,382	$	414,702	$	776,084
September 30, 2017		325,408		306,666		632,074

Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts

		Three Months Ended			Nine Months Ended
		June 30,			June 30,
	2018		2017		2018		2017
Segment operating income	$	35,708	$	27,322	$	95,449	$	66,097
Amortization of acquired intangible assets		5,080		3,278		14,298		9,636
Restructuring charges		82		828		131		2,663
Other unallocated corporate expenses		3,867		4,446		9,682		7,066
Total operating income	$	26,679	$	18,770	$	71,338	$	46,732

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

	June 30,		September 30,
	2018		2017
Segment assets	$	776,084	$	632,074
Cash, cash equivalents and marketable securities		231,983		104,292
Deferred tax assets		46,312		1,692
Equity method investments		37,051		28,570
Total assets	$	1,091,430	$	766,628